Vesprini D, Narod SA, Trachtenberg J, Crook J, Jalali F, Preiner J, et al. The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers. CUAJ [Internet]. 2013 Apr. 2 [cited 2026 Apr. 30];5(2):E31-E35. Available from: https://cuaj.ca/index.php/journal/article/view/619